Quote OVID abril 17, 2026 | 07:55 PMBloomberg Linea

OVID

OVID THERAPEUTICS INC

2.91 USD

+0.10+3.57%

YTD

OPEN2.83

PREV CLOSE2.81

VOLUME46.3k

MARKET CAP439m

1 YEAR+950.25

LOW 52 WEEK0.27

HIGH 52 WEEK3.11

YTD+78.77

DAY RANGE2.82 - 2.93

52 WEEK RANGE0.27 - 3.11

Historical data about OVID rate

Date	Time	Price
4/17/2026	1:30:00 PM	2.845
4/17/2026	1:35:00 PM	2.835
4/17/2026	1:40:00 PM	2.83
4/17/2026	1:45:00 PM	2.85
4/17/2026	1:50:00 PM	2.835
4/17/2026	2:00:00 PM	2.87
4/17/2026	2:10:00 PM	2.875
4/17/2026	2:30:00 PM	2.87
4/17/2026	2:40:00 PM	2.87
4/17/2026	2:45:00 PM	2.865

Date

Time

Price

4/17/2026

1:30:00 PM

2.845

4/17/2026

1:35:00 PM

2.835

4/17/2026

1:40:00 PM

2.83

4/17/2026

1:45:00 PM

2.85

4/17/2026

1:50:00 PM

2.835

4/17/2026

2:00:00 PM

2.87

4/17/2026

2:10:00 PM

2.875

4/17/2026

2:30:00 PM

2.87

4/17/2026

2:40:00 PM

2.87

4/17/2026

2:45:00 PM

2.865

Last news

Milei’s Chainsaw Minister Has 49 Days to Push Through Reforms Without Congress

In an interview with Bloomberg Línea, Federico Sturzenegger outlined plans for sweeping state reforms before delegated powers expire in July. He also explained why he believes these changes will outlast the current administration

Brazil Bus Startup Buser Eyes Acquisitions After First Profit

Co-founder and CEO, Marcelo Abritta, explained the strategy behind the startup’s more than US$100M in revenue and plans to grow by 50% in 2025

Exclusive: Colombia’s Finance Chief Seeks Fiscal Rule Changes, Downplays New Tax Reform

Finance Minister Diego Guevara told Bloomberg Linea the central bank’s new co-directors are technically qualified, while bringing a broader vision to monetary policy compared to their predecessors

Argentina Could Reach Investment Grade Under Milei, Says Top-Performing Macro Fund of 2024

Discovery Capital Management founder Rob Citrone told Bloomberg Línea that capital flows to the country should surge once capital controls end. The hedge fund led returns among peers last year